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ABSTRACT 
 
Background: 
Quadriparesis is a major disabling health problem. Its importance is due to the 
incapacitating disability that often persists despite treatment. It encompasses a large 
range of disease entities ranging from degenerative, demyelination, infection, 
familial, autoimmune, cerebrovascular accident and space occupying lesion in the 
brain. 
 
Aim of the study: 
Is to study the etiologies and clinical presentation of quadriparesis in sudanese 
patients. 
 
Material and methods: 
This is a descriptive cross -sectional study of 100 patients admitted in Al 
Shaab Teaching Hospital from Jan.2002-Oct.2003, presented with four limbs 
weakness. 
 
Results: 
There were 55 male and 45 female, more than half of the patients (55%) were 
in the  age group of 18-44. Patients were originally from different states and 
different racial groups. 75% of the patients presented with gradual onset. Weakness 
was the presenting complaint in all patients .39% of the patients were wheel chair 
bounded. 
 VII
CSF analysis showed high protein in12 patients(75%) with acute 
inflammatory demyelinating polyradiculoneuropathy , and in 14 patients (94%) with. 
Chronic inflammatory demyelinating polyradiculoneuropathy. Creatine 
phosehokinase was significantly high in all patients with muscular dystrophy. MRI 
detects the lesion in all patients with cervical cord compression. 
  
Conclusion:     
Cervical cord compression, acute inflammatory demyelinating 
polyradiculopathy, chronic inflammatory demyelinating polyradiculopathy, motor 
neuron disease  and muscular dystrophy constituted the etiological bulk of 
quadriparesis in the study. 
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  ﻣﻠﺨﺺ اﻷﻃﺮوﺣﺔ
 
ﻳﻌﺘﺒѧѧﺮ اﻟѧѧﺸﻠﻞ  اﻟﺮﺑѧѧﺎﻋﻰ ﻣѧѧﻦ اﻟﻤﻌﻮﻗѧѧﺎت اﻟѧѧﺼﺤﻴﺔ اﻟﻬﺎﻣѧѧﺔ  وذﻟѧѧﻚ ﻳﻌѧѧﻮد اﻟѧѧﻰ اﻟﻌﺠѧѧﺰ اﻟѧѧﺬى ﻳﺨﻠﻔѧѧﻪ          
ل و ﺗﺘѧѧﺮاوح اﺳѧѧﺒﺎب اﻟѧѧﺸﻠﻞ اﻟﺮﺑѧѧﺎﻋﻰ ﺑѧѧﻴﻦ اﻣѧѧﺮاض اﻧﺤﻼﻟﻴѧѧﺔ ؛ زوا.  اﻟﻤѧѧﺮض اﺣﻴﺎﻧѧѧﺎ  رﻏѧѧﻢ اﻟﻌѧѧﻼج 
.                                                                اﻟﻨﺨﺎﻋﻴﻦ؛ ﺧﻤﺠﻴﺔ؛ وراﺛﻴﺔ ؛ ﻣﻨﺎﻋﻴﺔ؛ ﺻﺪﻣﺔ ﻋﺼﺒﻴﺔ؛ و أورام دﻣﺎﻏﻴﺔ
أﺟﺮﻳѧﺖ هѧﺬﻩ . ﻟﺮﺑѧﺎﻋﻰ و ﻣﻈﺎهﺮهѧﺎ اﻟѧﺴﺮﻳﺮﻳﺔ اﻟﻬѧﺪف ﻣѧﻦ اﻟﺪراﺳѧﺔ هѧﻮ ﻣﻌﺮﻓѧﺔ ﻣѧﺴﺒﺒﺎت اﻟѧﺸﻠﻞ ا
 اﻟѧѧﻰ اآﺘѧѧﻮﺑﺮ 2002اﻟﺪراﺳѧѧﺔ اﻟﻤﻘﻄﻌﻴѧѧﺔ اﻟﻮﺻѧѧﻔﻴﺔ ﻓѧѧﻰ ﻣﺴﺘѧѧﺸﻔﻰ اﻟѧѧﺸﻌﺐ اﻟﺘﻌﻠﻴﻤѧѧﻰ ﻓѧѧﻰ اﻟﻔﺘѧѧﺮة ﻣѧѧﻦ ﻳﻨѧѧﺎﻳﺮ 
  . ﻟﻤﺎﺋﺔ ﻣﺮﻳﺾ ﻳﻌﺎﻧﻮن ﻣﻦ ﺿﻌﻒ آﻞ اﻻﻃﺮاف اﻟﻌﻠﻴﺎ و اﻟﺴﻔﻠﻰ 3002
ﻣѧѧﻦ % 55.ﻣѧѧﻦ اﻻﻧѧѧﺎث % 54ﻣѧѧﻦ اﻟﻤﺮﺿѧѧﻰ آѧѧﺎﻧﻮا ﻣѧѧﻦ اﻟѧѧﺬآﻮر و % 55أﻇﻬѧѧﺮت اﻟﻨﺘѧѧﺎﺋﺞ أن 
ﻣѧﻦ % 57.   ﺳѧﻨﺔ وهѧﻢ ﻣѧﻦ ﻣﺨﺘﻠѧﻒ أﻧﺤѧﺎء اﻟѧﺴﻮدان و أﻋﺮاﻗѧﻪ 44-81ﺮﺿﻰ ﺗﺘﺮاوح أﻋﻤﺎرهﻢ ﺑѧﻴﻦ اﻟﻤ
آѧﻞ اﻟﻤﺮﺿѧﻰ آѧﺎﻧﻮا ﻳﻌѧﺎﻧﻮن ﻣѧﻦ ﺿѧﻐﻒ . اﻟﻤﺮﺿﻰ ﻇﻬﺮت ﻋﻠﻴﻬﻢ أﻋﺮاض اﻟﻤﺮض ﺑﺼﻮرة ﺗﺪرﻳﺠﻴѧﺔ 
                 .                                ﻣﻦ  اﻟﻤﺮﺿﻰ  ﻻ ﻳﺴﺘﻄﻴﻌﻮن اﻟﺤﺮآﺔ ﻋﻠﻰ أﻗﺪاﻣﻬﻢ اﻃﻼﻗﺎ %93.اﻻﻃﺮاف اﻻرﺑﻊ 
 ﻣѧﺮﻳﺾ ﺑѧﺪاء اﻋѧﺘﻼل  اﻻﻋѧﺼﺎب اﻟﻤﺘﻌѧﺪدة 21 ﻓﺤѧﺺ ﺳѧﺎﺋﻞ اﻟﻨﺨѧﺎع اﻟѧﺸﻮآﻰ آѧﺎن داﻋﻤѧﺎ ﻟѧﺪى 
 ﻣѧﺮﻳﺾ ﺑѧﺪاء اﻋѧﺘﻼل اﻻﻋѧﺼﺎب اﻟﻤﺘﻌѧﺪدة زوال 41زوال اﻟﻨﺨѧﺎﻋﻴﻦ اﻟﺤѧﺎد ؛ و آѧﺎن أﻳѧﻀﺎ داﻋﻤѧﺎ ﻟѧﺪى 
اﻋﻤѧﺎ ﻟѧﺪى آѧﻞ ﻣﺮﺿѧﻰ اﻟﺤﺜѧﻞ ﻓﺤѧﺺ اﻧѧﺰﻳﻢ اﻟﻜﺮﻳѧﺎﺗﻴﻦ ﻓѧﺴﻔﻮآﺎﻳﻨﻴﺰ آѧﺎن اﻳﺠﺎﺑﻴѧﺎ و د . اﻟﻨﺨﺎﻋﻴﻦ اﻟﻤﺰﻣﻦ 
  .اﻟﺘﺨﻄﻴﻂ  ﺑﺎﻟﺮﻧﻴﻦ اﻟﻤﻐﻨﻄﻴﺴﻰ دﻋﻢ ﺗﺸﺨﻴﺺ آﻞ ﺣﺎﻻت اﻧﻀﻐﺎط اﻟﺤﺒﻞ اﻟﺸﻮآﻰ اﻟﺮﻗﺒﻰ.اﻟﻌﻀﻠﻰ 
؛ اﻋѧѧﺘﻼل اﻻﻋѧѧﺼﺎب اﻟﻤﺘﻌѧѧﺪدة زوال  %(62) ﺗѧѧﺸﻜﻞ آѧѧﻞ ﻣѧѧﻦ اﻧѧѧﻀﻐﺎط اﻟﺤﺒѧѧﻞ اﻟѧѧﺸﻮآﻰ اﻟﺮﻗﺒѧѧﻰ 
؛ %(51) ؛ اﻋѧѧѧѧѧﺘﻼل اﻻﻋѧѧѧѧѧﺼﺎب اﻟﻤﺘﻌѧѧѧѧѧﺪدة زوال اﻟﻨﺨѧѧѧѧѧﺎﻋﻴﻦ اﻟﻤѧѧѧѧѧﺰﻣﻦ  % ( 61)اﻟﻨﺨѧѧѧѧѧﺎﻋﻴﻦ اﻟﺤѧѧѧѧѧﺎد 
اﻻﺳѧﺒﺎب اﻻﺳﺎﺳѧﻴﺔ اﻟﺨѧﺰل  اﻟﺮﺑѧﺎﻋﻰ ﺑﻬѧﺬﻩ %(  01)و اﻟﺤﺜѧﻞ اﻟﻌѧﻀﻠﻰ %( 01)داءاﻟﻌﺼﺒﻮن اﻟﺤﺮآѧﻰ 
  .اﻟﺪراﺳﺔ 
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INTRODUCTION: 
Quadriparesis is weakness affecting all four limbs, can result from upper 
motor neuron disease (localized to the upper cervical spinal cord or above), diffuse 
lower motor neuron disease, or myopathy (1). 
 
Acute Quadriparesis: 
The differential diagnosis for acute quadriparesis with onset over minutes 
includes many diseases of upper motor neuron e.g. (anoxia, hypotension, brainstem or 
cervical cord ischemia, trauma and systemic metabolic abnormalities) and also rare 
forms of myopathic weakness (systemic toxins or periodic paralysis) (1). 
Onset over hours to a few days may be due to upper motor neuron, lower 
motor neuron or myopathic disorders (1). 
All three pattern of weakness are usually associated initially with hypotonia (1). 
If acute quadriparesis is associated with stupor or coma, the evaluation begins 
with a CT-Scan of the brain (1). 
If upper motor neuron signs are present but the patient is alert, the initial test 
is usually MRI of the cervical cord (1). 
If weakness is lower motor neuron, myopathic, or uncertain in origin, the 
clinical approach starts with an electro diagnostic study (1). 
Acute demyelinating polyneuropathy is an important diagnostic possibility in 
this setting (1). 
 
Sub acute or chronic quadriparesis: 
When quadriparesis due to upper motor neuron disease develops over weeks, 
months, or years, the distinction between disorders of the cerebral hemispheres, 
brainstem, and cervical spinal cord is usually possible by clinical criteria alone (1). 
The diagnostic approach begins with MRI of the clinically suspected site (1). 
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Lower motor neuron disease present with weakness that is most profound 
distally where as myopathic weakness is typically proximal. 
The evaluation then begins with EMG and nerve conduction studies (1).    
 
NEUROANATOMY OF THE MOTOR SYSTEM: 
 There are three systems: 
• The corticospinal or (pyramidal) system, originate in the cerebral cortex and 
delivers information to the anterior horn cells of the spinal cord. This system 
enables purposive, skilled, strong and organized movement to take place. 
Defective function within the pathway is recognized by a distinct pattern of loss 
of skilled voluntary movement, spasticity and reflex changes (2). 
• The extra pyramidal system, facilitate fast, fluid movement that the corticospinal 
system has generated. Defective function is recognized usually by slowness 
(bradykinesia), stiffness (rigidity) and/or disorders of movement (rest tremor, 
chorea and dyskinesias) (2). 
• The cerebellum and its connections have a role in coordinating the smooth 
movement initiated by the corticospinal system, and in the regulation of balance 
(2). 
 
The corticospinal or (pyramidal) system: 
The corticospinal tracts originate in the neurons of the fifth layer of the cortex 
and terminate at the motor nuclei of the cranial nerves and anterior horn cells of the 
spinal cord. The nerve fiber pathways of a particular importance in clinical diagnosis 
congregate in the internal capsule and cross in the medulla (decussating of the 
pyramids).Passing to the contra lateral halves of the spinal cord as the crossed lateral 
corticospinal tracts(2). 
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This is the pyramidal system disease of which causes upper motor neuron 
(UMN) lesions. 
A small proportion of the corticospinal outflow remains uncrossed (the 
anterior corticospinal tracts) but this is not of relevance in clinical practice. 
The lower motor neuron (LMN) is the motor pathway from the anterior horn 
cell (or cranial nerve nucleus) via a peripheral nerve to the motor end plate (2). 
The motor unit consist of the a single anterior horn cell, the single fast- 
conducting motor nerve fiber that leaves the spinal cord via the anterior root, and the 
group of muscle fibers (100-200) being supplied via the mixed peripheral nerve. 
Anterior horn cell activity is modulated by impulses from the corticospinal tracts, the 
extra pyramidal system, the cerebellum and afferent fibers from the posterior roots (2). 
 
CERVICAL CORD COMPRESSION 
Cervical Spondylosis: 
Cervical spondylosis results from chronic cervical disc degeneration, with 
herniation of disc material, secondary calcification and associated with osteophytic out 
growth. One or more of the cervical nerve roots may be compressed, stretched, or 
angulated, and myelopathy may also develop as a result of compression, vascular 
insufficiency, or recurrent minor trauma to the cord (3). 
Patients present with neck pain and restricted head movement, occipital 
headache, radicular pain and other sensory disturbances in the arms, weakness of the 
arms or legs, or some combination of these symptoms (3). 
Examination generally reveals that lateral flexion and rotation of the neck are 
limited. A segmental pattern of weakness or dermatomal sensory loss or both may be 
found unilaterally or bilaterally in the upper limbs, and tendon reflexes mediated by the 
affected root or roots are depressed (3). 
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The C5 and C6 nerve roots are most commonly involved, and the examination 
frequently then reveals weakness of the muscle supplied by these roots (deltoid, supra. 
and infraspinatus, biceps, brachioradialis), pain or sensory loss about the shoulder and 
outer border of the arm and forearm, and depressed biceps and brachioradialis reflexes 
.Spastic paraparesis may also be present if there is an associated myelopathy, 
sometimes accompanied by posterior column or spinothalamic sensory deficit in the 
legs (3). 
Degeneration of cervical discs and joints may occur in adolescents but is more 
common after age of 40. Degeneration is progressive and is marked by gradual 
narrowing of the disc space, as demonstrated by x-ray. Osteocartilaginous proliferation 
occurs around the margin of the vertebral body and gives rise to osteophytic ridges that 
may encroach upon the intervertebral foramina and spinal canal, causing compression 
of the neurovascular contents(4). 
              Osteoarthritis of the cervical spine is often a symptomatic but may cause 
diffuse neck pain, radicular pain or myelopathy. Myelopathy develops insidiously and 
is manifested by numb, clumsy hands. Some patients also complain of unsteady 
walking, urinary frequency and urgency, or electrical shock sensation with neck flexion 
or extension (Lhermitte’s sign).weakness, sensory loss and spasticity with exaggerated 
reflexes develop below the level of the spinal cord compression (4).  
Plain radiographs of the cervical spines show osteophyte formation, 
narrowing of the disc spaces and encroachment on the vertebral foramina, but many 
changes are common in middle-aged persons and may be unrelated to the presenting 
complaint (3). 
CT or MRI helps to confirm the diagnosis and exclude other structural causes 
of the myelopathy (3). 
Restriction of neck movements by a cervical collar may relieve the pain. 
Operative treatment may be necessary to prevent further progression if there is a 
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significant neurological deficit or if root pain is severe, persistent, and unresponsive to 
conservative measures (3). 
Atlatoaxial subluxation may occur in patient with rheumatoid arthritis, 
regardless of the severity of the disease. Inflammation of the synovial structures 
resulting from erosion and laxity of the transverse ligament can lead to neurological 
signs of the spinal cord compression (4). 
Treatment may vary with from use of a cervical collar or more rigid bracing 
to operative treatment, depending on the degree of subluxation and neurologic 
progression. Surgical treatment may involve stabilization of the cervical spine (4). 
 
Spontaneous Cervical Spinal Epidural Hematoma: 
It is an uncommon entity. In the absence of trauma spinal epidural hematoma 
are considered spontaneous (5). 
The most common causes are anticoagulant therapy, vascular anomalies, 
hypertension, and blood spinal surgery (6). 
In up to 40% of cases, no underlying case can be identified (7). 
The clinical picture is that of acute spinal cord compression, beginning with 
local back and radicular pain followed by sensory changes and finally motor weakness 
or paralysis. This symptom complex evolves within hours (8). 
The standard therapy has been prompt evacuation of the haematoma, usually 
with good neurological recovery (9). 
Spontaneous resolution and complete recovery without surgical 
decompression was reported in few cases (10). 
 
Spinal Cord Tumors: 
10% of the spinal cord tumors are inframedullary. Ependymoma is the most 
common type of inframedullary tumor. Extramedullary tumors may be extradural or 
 XV
intradural in location. The primary extramedullary tumors, neurofibromas and 
meningiomas, are relatively common; are benign and may be intra or extradural (11). 
Carcinomatous metastasis, lymphomatosis or leukemic deposit and myeloma 
are usually extradural, in the case of metastases; the prostate, breast, lungs and kidney 
are common primary sites (11). 
Tumors may lead to spinal cord dysfunction by direct compression, by 
ischemia secondary to arterial or venous obstruction and, in cases of intramedullary 
lesion, by invasive infiltration (11). 
CT myelography or MRI may be necessary to identify and localize the site of 
cord compression (11). 
CSF is often xanthochromic and contains high protein concentration, with 
normal cells count and glucose concentration (11). 
Treatment with high dose of dexamethasone is used to reduce cord swelling 
and irradiation therapy to delay the onset of disability. Intramedullary tumors are 
treated by surgical excision and decompression (11). 
 
ACUTE INFLAMMATORY DEMYELINATING 
POLYRADICULONEUROPATHY:  
Background: Acute inflammatory demyelinating polyradiculoneuropathy (AIDP) is an 
autoimmune process that is characterized by progressive weakness many variants exist. 
This associated with distal paraesthesia and loss of deep tendon reflexes (12). 
Myelin breakdown and axonal degeneration were observed in nerve biopsies 
from patients with (AIDP) by Haymaker and Kernohan in 1949. An allergic etiology 
was suggested by Krucke in 1955 after he observed lymphocytic infiltrates within 
biopsy specimens (13).   
  
 XVI
Pathophysiology: AIDP is believed to be caused by an immunologic attack that is 
directed against myelin components. This result in a demyelinating  
Polyneruropathy, both cellular and humoral immune mechanisms appear to 
play a role. Early inflammatory lesions consist of a lymphocytic infiltrate that is 
adjacent to segmental demyelination. Macrophages are more prominent several days 
later (13).  
The changes are observed in nerve roots, and cranial nerves. In acute motor 
axonal neuropathy (AMAN, an AIDP variant), deposited complement is found at the 
nodes of Ranvier. While myelin often is left undamaged (14). 
Damage to the myelin sheath leads to segmental demyelination. This results 
in decreased nerve conduction velocity and, at times, conduction block. Occasionally, 
in more sever and rapid cases, axonal degeneration also is observed which results in 
wallerian degeneration (14). 
Causes: AIDP is thought to be caused by a dysregulated  immune response against 
myelin .This  response may be triggered by several illnesses and conditions .Tow thirds 
of patients with AIDP recall  an antecedent upper respiratory or gastrointestinal 
infection eg campylobacter jejuni (15). 
Several cases have been reported after immunization against rabies, influenza, 
measles, mumps, or rubella (15). 
 
History: Classically, AIDP present as an ascending paralysis. Even in these cases, the 
clinical presentaion and course vary. Additionally, many variants exist that differ 
markedly from classic AIDP in disease onset or course. 
The hallmark of classic AIDP is progressive weakness that usually begins in 
the feet  before involving all four limbs .At presentation , 60% of patients have 
weakness in all four limbs .Weakness plateaus  at two weeks after onset in 50%of 
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patients  and  by four weeks in over 90% . It is usually symmetric, although mild 
asymmetry is not uncommon early in the disease course .In the arms, weakness may be 
worse proximally than distally. At presentation, half of patients have some facial 
weakness, although only 5% have varying degrees of ophthalmoplegia (12, 16). 
Forty percent have oropharyngeal or respiratory weakness at presentation. 
Improvement in strength usually begins 1-4 weeks after the plateau. About one third of 
patients require mechanical ventilation because of respiratory failure (12). 
Sensory system, mild to moderate severe paraesthesias in the distal limbs are 
common and often precede the onset of weakness by 1 or more days .Proximal sensory 
changes are uncommon but may occur in more severe cases of AIDP (17). 
About two third of patients have one or more autonomic abnormaities 
.Sustained sinus tachycardia is the most common dysfunction. Postural hypotension 
leading to presyncope or syncope can occur. Sweating dysfunction is common but 
rarely noted by patients. Urinary retention and constipation are more likely to occur 
lately in the course of AIDP (18).  
The Miller–Fisher variant is presented with ophthalmolegia, areflexia and 
ataxia (19).  
  
Physical: Although patients often report only weakness in the leg, careful examination 
usually demonstrates arm weakness (proximally and distally some patients with Miller 
–fisher or other regional variants may have weakness of cranial muscles only (12). 
Deep tendon reflexes, hyporeflexia or areflexia is seen in70%of patients at 
presentation and eventually in all patients. A progressive decrease in reflexes is a useful 
finding that may precede EMG changes (12).  
Fluctuations in heart rate, specifically a sustained sinus tachycardia, are seen 
often .Some intubated patients also may have bradycardia, especially after vagal 
stimulation with Valsalva and/or tracheal suctioning maneuvers (18). 
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Orthostatic hypotension can occur and is likely due to dysfunction of 
baroreceptor reflex (18). 
At times, the labile blood pressure is observed with severe hypertension that 
may be due to dysfunction of the afferent of the baroreceptor reflex. (18). 
   
C.S.F: Increased CSF protein without an increased WBC count (albuminocytologic 
dissociation) is observed classically in AIDP. However, this finding is not specific to 
AIDP. About two thirds of patients have this CSF finding during the first week of 
symptoms and 82% have it by 2 weeks after symptoms onset. Although protein values 
can be elevated by 10 –fold or more, no association exists between protein level and 
clinical severity (14).  
Nerve studies (NCS) can document demylination, the hallmark of AIDP. 
Early on findings of NCS studies are often normal. However, 90% are abnormal within 
3 weeks of symptom onset (20). 
Pulmonary function tests, useful in determining the timing of unit (ICU) 
transfer and intubation, should be performed in all patients (21). 
Transfer to ICU generally is indicated when Forced vital capacity  (FVC) is 
less than 20 ml/kg. Intubation usually is warranted when FVC drop to 15 ml/kg or 
negative inspiratory pressure drop to less than –25 cm H2O (21). 
Electrocardiogram (ECG) and cardiac monitoring can be helpful when 
arrhythmias occur. Other possible abnormalities include atrioventricular block, QRS 
widening, and T-wave abnormalities (21). 
  
Medical care: Mechanical ventilator assistance is required in about one third of patients 
with AIDP and lasts for an average of 49 days. Tracheostomy usually is recommended 
if mechanical ventilation will be required for more than 2-3weeks (21). 
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Cardiac monitoring is necessary .Chronic sinus tachycardia often responds to 
beta – blockers or calcium channel blockers. Bradycardia requires atropine treatment, if 
symptomatic .Heart block may require temporary pacing. Hypertension responds well 
to beta –blockers (21). 
Immunomodulation with IV immunoglobulin and plasmapheresis has led to 
faster recovery, relatively mild disability, and shorter hospital stays (22). 
 
Prognosis: About 75% of patients have an excellent recovery and regain their pre-
morbid condition. Some of these patients experience easy fatigability for many years. 
Death occurs in only 2-6%of patients and is usually due to cardiac arrest, ARDS, 
pulmonary embolism, severe bronchospasm, pneumonia, and sepsis (23). 
   
CHRONIC INFLAMMATORY DEMYELINATING 
POLYRADICULONEUROPATHY: 
 
CIDP is an acquired immunological mediated disorder, is clinically similar to 
GBS except in that it has relapsing or steadily progressive course over months or years 
(24). 
In the relapsing form, partial recovery may occur after some relapses, but in 
other instances there is no recovery between exacerbations (24).   Although remission 
may occur spontaneously with time, the disorder frequently follows a progressive 
downhill course leading to severe functional disability (24). 
CSF shows elevated protein level not accompanied by pleocytosis and 
electrophysiological changes (25). 
Electro diagnostic studies show marked slowing in motor and sensory 
conduction, and focal conduction block. Signs of partial denervation may be present 
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owing to secondary axonal degeneration. Nerve biopsy may show chronic perivascular 
inflammatory infiltrates, without accompanying evidence of vasculitis (24). 
Corticosteroids may be effective in arresting or reversing the downhill course 
(24). 
Treatment is usually begun with prednisolone 60mg daily, for 2-3 months or 
until a definite response has occurred. If no response has occurred despite 3 months of 
treatment, a higher dose may be tried. In responsive cases, the dose is gradually 
tapered, but most of patients become corticosteroids-dependent, often requiring 
prednisolone 20mg daily on alternate days, on along term basis (24). 
Patients unresponsive to corticosteroids may benefit instead from treatment 
with cytotoxic drugs such as azathioprine, cyclophosphamide or cyclosporine and 
administration of high dose intravenous, immunoglobulin treatment (e.g:400mg/kg/day) 
produce clinical improvement lasting for weeks to months (24). 
 
* MUSCULAR DYSTROPHY: 
These inherited myopathic disorders are characterized by progressive muscle 
weakness and wasting (26). 
They are subdivided by mode of inheritance, age of the onset and the clinical 
features (26). 
In the Duchenne type, pseudo hypertrophy of muscles frequently occurs at 
some stage; intellectual retardation is common; and there may be skeletal deformities, 
muscle contractures and cardiac involvement. The serum CPK level is increased, 
especially in Duchenne and Becker varieties, and mildly increased in the limb girdle 
dystrophy. EMG may help to confirm that the weakness is myopathic rather than 
neurogenic(26). 
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A genetic defect on the short arm of the X chromosome has been identified in 
Duchen-ne dystrophy. The affected gene codes for the protein dystrophin, which is 
markedly reduced or absent from the muscle of patients with the disease (26). 
Dystrophin level is generally normal in the Becker variety, but the protein is 
qualitatively altered. 
It is important to encourage patients to lead as normal live as possible. 
Prolonged bed rest must be avoided, inactivity often lead to worsening of underlying 
muscle disease (26). 
Physical therapy and orthopedic procedures may help to counteract 
deformities or contractures (26). 
        
Limb girdle muscular dystrophy: 
             Clinical features: Muscle weakness affects both male and females, with onset 
ranging from late in the first decade to the fourth decade. Most limb-girdle   muscular   
dystrophies   are progressive and affect the pelvis and shoulder girdle muscles (27). 
Respiratory insufficiency from diaphragm weakness may occur. The 
distribution of weakness and the   rate   of progression vary from family to another. 
Cardiac involvement results in congestive heart failure or arrhythmias; occasionaly 
patients present with cardiomyopathy. Intellectual function remains normal (27). 
Laboratory features: An elevated serum CPK level, myopathic EMG findings, and 
muscle biopsy features indicative of myopathy represent the characteristic changes in 
limb–girdle dystrophy (27).  
Treatment: Supportive care, no specific treatment, wheel-chair may be essential or may 
be used to help preserve energy in work. Cardiac or respiratory muscle involvement 
may require individualized treatment (28). 
         
MOTOR NEURON DISEASE (MND): 
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MND is characterized clinically by weakness and variable wasting of the 
affected muscles, without accompanying sensory changes (29). 
MND mainly affect adults between 30 and 60 years of age. Theres is 
degeneration of the anterior horn cells in the spinal cord, the motor nuclei of the lower 
cranial nerves, and the corticospinal and corticobulbar tract . Generally have the poorest 
prognosis (29). 
 
Classification: Five varieties have been distinguished on clinical grounds: 
             (A) Progressive bulbar palsy: Bulbar involvement predominates owing to 
disease processes affecting primarily the motor nuclei of the cranial nerves. 
             (B) Pseudo bulbar palsy: Bulbar involvement predominates in this variety also, 
but it is due to bilateral corticobulbar disease and thus reflects upper motor neuron 
dysfunction. 
            (C) Progressive spinal muscular atrophy: This characterized primarily by a 
lower motor neuron deficit in the limbs due to generation of the anterior horn cells in 
the spinal cord. 
            (D) Primary lateral sclerosis: There is a purely upper motor neuron deficit in 
the limbs (29).  
            (E) Amyotrophic lateral sclerosis (ALS): This is progressive, fatal motor 
neuron disease of unknown origin causes selective degeneration of both upper and 
lower motor neurons. Widespread loss of these neuronal links between the brain and 
skeletal muscle results in generalized muscle weakness and atrophy (30). 
Progressive respiratory in sufficiency is usually the cause of    death (30). 
Onset of ALS is usually from middle to late adulthood, but persons of any age 
can be affected. Most cases of ALS occur sporadically, but an autosomal dominant is 
seen in 5% of patients (30). 
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Symptoms & Signs : The common clinical manifestation related to degeneration of 
upper and lower motor neuron function in ALS include: spasticity, hyperreflexia, 
muscle weakness, muscle atrophy, fasciculation, hyporeflexia, hypotonia, muscle 
cramps, dysartheria, dysphagia, exertional dyspnoea, respiratory failure, fatigue, 
insomnia, weight loss, tendon shortening and joint contracture(31). 
The disease begins with focal motor weakness at a specific brain stem or 
spinal level, then progress to involvement of contiguous spinal levels (31). 
The clinical hallmark of the ALS is the presence of widespread,   purely 
motor signs of both upper and lower motor neuron dysfunction. ALS spares cognitive 
function, but this feature has potentially negative effects because patients remain fully 
aware of the progression of their disease (32).  
Diagnosis by EMG is confirmed by the presence of widespread, purely motor 
denervation of lower motor neurons (32). 
MRI studies are useful to exclude other possible disorders. Because ALS is a 
selective motor neuron disease, clear evidence of cognitive, visual, bladder, bowel, or 
sensory symptoms does not support the diagnosis (33).               
Treatment by Riluzole is an important break through because it    prolongs 
survival by about 3 months, making it the only effective disease-specific therapeutic 
option (34). 
 
SPACE OCCUPYING LESIONS (SOL): 
Primary intracranial tumors lead to focal deficit depending on their location 
(35). 
Meningiomas: 
Meningiomas are derived from cells of the arachnoid granulations. These 
usually benign tumors, they attached to the dura and may invade the skull but almost 
never invade the brain (36). 
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They frequently occur along the sagittal sinus and over the cerebral 
convexities, in the cerebellar-pontine angle and along the dorsum of the spinal cord. 
They are more frequent in women than men, with a peak incidence in middle age. 
Meningioma may be found incidentally on a CT or MRI scan, or may present with a 
focal seizure, a slowly progressive focal deficit, or symptoms of increased intracranial 
pressure. The radiologic image of a dural-based, extra-axial mass with dense, uniform 
contrast enhancement is essentially diagnostic, although a dural metastasis must also be 
considered (36).  
Meningioma compresses rather than invades adjacent neural structures. 
Increasingly, common with advancing age. Tumor size varies greatly. Symptoms vary 
with tumor site; unilateral exophthalmus (sphenoidal ridge), anosmia and optic nerve 
compression (olfactory groove) (36).   
Meningioma may lead to calcification and bone erosion, visible on plain x-
rays of skull (36). 
Total surgical resection of benign meningioma is curative. If a total resection 
can not be achieved, local radiotherapy reduces the recurrence rate to less than 10 % (37). 
 
Tuberculous meningitis & tuberculoma: 
Tuberculosis of the CNS accounts for about 5% of extra pulmonary cases. It 
is seen most often in young children but also develop in adults, especially those who 
are infected with HIV. Tuberculous meningitis results from the haematogenous spread 
of primary or post primary pulmonary disease or from the rupture of a subependymal 
tubercle into the subarachnoid space. In more than half of the cases, evidence of old 
pulmonary lesion or miliary pattern is found on chest radiography. The disease may 
present as headache and mental changes or acutely as confusion, lethargy, altered 
Sensation and neck rigidity (38). 
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Typically the disease evolves over 1 or 2 weeks- a course longer than that of 
bacterial meningitis. Paresis of the cranial nerves (ocular nerves in particular) is 
frequent finding, and the involvement of cerebral arteries may produce focal ischemia 
(38). 
Hydrocephalus is common. Lumber puncture is the corner stone of diagnosis. 
In general examination of the CSF reveals a high leucocytes count (usually with 
predominance of lymphocyte but often a predominance of neutrophil in the early stage), 
protein content of 1 to 8 g/l or (100-800 mg/dl) and low glucose concentration, 
however; any of these three parameters can be within the normal range .AAFB is seen 
on direct smear of CSF sediment in only 20% of cases. Imaging studies (CT and MRI) 
may show hydrocephalus and abnormal enhancement of basal cisterns or ependyma. If 
unrecognized tuberculous meningitis is uniformly fatal (38). 
This disease responds to chemotherapy; neurological sequelae are 
documented in 25% of treated cases; in most of which the diagnosis has been delayed. 
Glucocorticoids are useful adjunct to chemotherapy, especially in cases with cerebral 
edema or high CSF protein level (38). 
 
Tuberculoma:  
An uncommon manifestation of tuberculosis, presents as one or more space-
occupying lesions and usually causes seizures and focal signs. CT or MRI reveals 
contrast-enhanced ring lesions, but biopsy is necessary to establish the diagnosis (38).  
 
Pott’s disease of cervical spine: 
Tuberculous arachnoiditis may arise at any level of the spinal cord in 
association with breakdown of a focus within the cord or meninges, or by extension 
from an adjacent area of in-apparent spondylitis .Cervical spine tuberculosis is a less 
common presentation but is serious (38).  
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POLYMYOSITIS – DERMATOMYOSITIS 
 
Background: Polymyositis is a systemic disorder of unknown cause whose principal 
manifestation is muscle weakness. It is the most frequent primary myopathy in adults. 
When skin manifestations are associated with it, the entity is designated 
dermatomyositis. The true incidence is not known, since milder cases are frequently not 
diagnosed.  The disease may affect person of any age group, but the peak incidence is 
in the fifth and sixth decades of life. Women are affected twice as commonly as men 
(39). 
There is an increased risk of malignancy, especially in patients with 
dermatomyositis. The malignancy maybe evident initially or may not-become evident 
for months after the muscle disease presents. Ovarian cancer appears to be especially 
common, found in some series to affect more than 20% of women aged over 40 with 
dermayomyositis (40).  
 
Symptoms & sign: Polymyositis may begin abruptly, although often it is gradual   and 
progressive. The characteristic rash is dusky red and   may be seen over the butter fly 
area of the face, neck, shoulder, and upper chest and back. Periorbital edema and 
purplish (heliotrope) suffusion over the upper eyelids are typical signs. Subungual 
erythema, cuticular telangiectases and scaly patches over the dorsum of the proximal 
interphalangeal and metacarpophalangeal joints (Gottron's sign) are highly suggestive 
(39). 
Muscle weakness chiefly involves proximal groups, especially of the 
extremities. Leg weakness (e.g.; difficulty rising from a chair or climbing steps) 
precedes arm symptoms. Neck flexor weakness occurs in 2/3 of the cases. Pain and 
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tenderness of affected muscles occur in 1/4 of the cases, and Raynaud’s phenomenon 
and joints symptoms may be associated. Atrophy and contractures occur late. 
Associated myocarditis is uncommon. Interstitial pulmonary disease, usually mild, is 
sometimes associated, and calcinosis may be observed, especially in children. 
Polymyositis may occur in association with sjogren,s syndrome, SLE or scleroderma 
(39).          
 
Laboratory findings: Measurement of serum level of muscle enzymes, especially CPK 
and aldolase, is the most useful in diagnosis and assessment of the disease activity (39). 
The search for an occult malignancy should be routine for the patients (40).  
Biopsy of clinically involved muscle, usually proximal, is the only specific 
diagnostic study (39).  
 
Management: Most patients respond to corticosteroids. Often a daily dose of 40-60 mg 
or more of prednisolone is required initially and then reduced gradually (39). 
 
BRUCELLOSIS: 
 
Brucellosis is a zoonotic disease caused by several brucella species. The   
most common causes of human disease are brucella melitensis and brucella Suis (41).      
Physical examination findings can include generalized lymphadenopathy and 
hepatosplenomegaly. Granulomas can be seen in the liver, spleen, bone marrow, lymph 
node, brain, skin and kidneys. Laboratory studies may show mild leucopenia or 
thrombocytopenia. Death occurs in less than 1% of cases, but brucellosis can cause 
significant illness for months to years (42). 
Neurobroucellosis: 
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Is uncommon but serious and include meningoencephalitis, multiple cerebral 
or cerebellar abscesses, rupture mycotic aneurysms, myelitis, Guillian-Barre syndrome, 
cranial nerve lesions, hemiplegia, sciatica, myositis and rhabdomyolysis. Papillitis, 
papilloedema, retrobulbar-neuritis, optic atrophy and ophthalmoplegia due to lesions in 
cranial nerves III, IV and VI   may occur in brucella meningoencephalitis. (43). 
Cerebrospinal fluid (CSF) pressure is usually elevated; the fluid may appear 
clear, turbid or hemorrhagic, the protein concentration and cell count (predominantly 
lymphocyte) are elevated; and the glucose concentration may be either reduced or 
normal. (43). 
In brucella meningitis, the organism may be cultured from the CSF. .(43). 
 
Treatment: Antimicrobial agents include tetracycline, doxycycline, streptomycin, 
gentamycin, trimethoprim-sulfamethoxazole and quinolones. (44)   
Because relapse is common with monotherapy, combination therapies with 
doxycycline and rifampin (Rifadin) or with doxycycline and streptomycin have been 
recommended by WHO. (45)   
 
STROKE: 
Cerebral Infarction:  
Thrombosis or embolic occlusion of a major vessel leads to cerebral 
infarction. Causes include the disorders predisposing to transient ischemic attacks and 
atherosclerosis of the cerebral arteries. The resulting deficits depend upon the particular 
vessel involved and the extent of any collateral circulation. Cerebral ischemia leads to 
release of excitatory and other neuropeptides that may augment calcium flux into 
neurons, thereby leading to cell death and increasing the neurological deficit. (46)   
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Symptoms & signs: Onset is usually abrupt, and there may be very little progression 
except that due to brain swelling. Clinical evaluation always includes examination of 
the heart and auscultation over the subclavian and carotid vessels to determine whether 
there are any bruits (47).  
 
Imaging: Radiography of the chest may reveal cardiomegaly or valvular calcification; 
the presence of a neoplasm would suggest that the neurological deficit is due to 
metastasis rather than stroke (46). 
CT scan of the head (without contrast) is important in excluding cerebral hemorrhage 
(46). 
 
Laboratory & Other Studies: Investigations should include a complete blood count, 
erythrocytes sedimentation rate, blood glucose determination and serological tests for 
syphilis. Antiphospholipid antibodies promote thrombosis and are associated with an 
increased incidence of stroke. Similarly, elevated serum cholesterol and lipids may 
indicate an increased risk of thrombotic arrhythmia or recent myocardial infarction (47). 
 
Treatment: Early management of completed stroke consist of attention  to general 
supportive measures during the acute  stage, there may be  marked brain swelling and 
edema, with symptoms and signs of increasing intracranial pressure and increasing 
neurological deficit or herniation syndrome(48). 
Attempt to lower the blood pressure of hypertensive patients during the acute 
phase of stroke should be avoided. Since there is loss of cerebral autoregulation, the 
lowering of the blood pressure may further compromise ischemic areas (48). 
Physical therapy has an important role in the management of patients with 
impaired motor function. Passive movements at an early stage will help in preventing 
contractures (48). 
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In all cases, early mobilization and active rehabilitation are important. 
Occupational therapy may improve morale and motor skills, while speech therapy may 
be beneficial in patients with expressive dysphasia or dysartheria (48). 
 
Prognosis: Loss of consciousness after cerebral infarcts implies a poorer prognosis. 
Patients who have had a cerebral infarct are at risk for further strokes and for 
myocardial infarcts (47). 
 
ENCEPHALITIS: 
Encephalitis is an acute inflammatory process that affects brain tissue and is 
most commonly caused by viral infection. Encephalitis resulting from viral infection 
manifests as either acute viral encephalitis or post infectious encephalomyelitis (49). 
The most frequently reported causes are; enteroviruses, herpes simplex virus 
type-1(HSV-1) and type-2 (HSV-2), and arthropod-borne viruses (Arboviruses). Before 
widespread of live measles, mumps, and rubella virus vaccine (MMR 11), mumps virus 
was also a common source of aseptic meningitis and encephalitis (50).  
Most patients with enterovirus CNS infection have mild generalized disease 
that resolves without ale. However, focal - infections and severe, even fatal, cases have 
been reported (51, 52). 
 
Symptoms and Signs: Include fever, headache, and behavioral changes. Subsequently, 
focal seizures, hemi paresis, cranial nerve deficits, and visual field abnormalities may 
occur (53). 
A score of less than 6 in GCS, age greater than 30 years, and presence of 
encephalitis for more than 4 days before initiation of therapy are predictive of severe 
sequelae or death. Most survivors of HSV encephalitis have neurological sequel 
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ranging from impaired new learning to severe motor and sensory deficit, aphasia, and 
amnestic syndrome. Encephalitis may recur despite appropriate antiviral therapy (53). 
Arboviruses are RNA viruses transmitted to vertebrate hosts by 
hematophagous arthropods, such as mosquitoes and ticks. Such viruses cause about 10 
% of all reported cases of sporadic encephalitis but may account for up to 50% of all 
cases in epidemic years (54).    
HIV may be the primary cause of encephalitis in persons with AIDS; 
however, opportunistic infections also must be considered (55).   
 
Post-infectious Encephalomyelitis: 
Post infectious encephalomyelitis is characterized by periventricular 
inflammation and demyelination of brain tissue. In this disorder, peripheral blood 
lymphocytes react against myelin basic protein. Before widespread vaccination, Post 
infectious encephalomyelitis most commonly occurred after smallpox and measles 
infections. Recent years, the disease had been associated with various viral and 
bacterial infections (56, 57). 
Patients may have a history of nonspecific respiratory or gastrointestinal 
illness for 1 to 2 weeks before the onset of neurological symptoms (58). 
Acute cerebellar ataxia is a form of acute Post infectious encephalomyelitis 
following varicella infection. 
Examination of the CSF in a patient with viral CNS infection reveals a normal 
or elevated opening pressure. A moderate elevation in white cells count is typical. 
Polymorph nuclear cells may predominate early in the illness, but are replaced by 
mononuclear cells within hours. Other typical CSF findings include a normal or 
elevated protein level and a normal glucose level. A routine Gram-stain should be 
obtained; in addition, CSF should be cultured for bacteria, viruses, fungi and 
mycobacterium (58).   
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Polymerase Chain Reaction (PCR) is being more widely used to detect viral 
DNA or RNA in CSF .This method has been reported to have greater than 95% 
sensitivity and 100% specifity for HSV DNA in patients with biopsy-proven HSV 
encephalitis (59).  
PCR techniques show excellent specifity and sensitivity in the diagnosis of 
enteroviral meningitis appears promising (51).  
EEG is a useful complementary test for diagnosis of encephalitis in patients 
with HSV encephalitis, EEG may reveal focal unilateral or bilateral periodic discharges 
localized in the temporal lobe (60.   
Brain biopsy is the definite test for diagnosis of acute encephalitis. Biopsy 
should be considered in cases in which the diagnosis is uncertain and response to 
therapy is poor (60). 
 
Treatment: Empirical therapy with intravenous acyclovir should be initiated when 
HSV encephalitis is suspected. The recommended dosage is 30 mg/kg/day in three 
divided doses for 14 to 21 days. Relapse may occur, and re- treatment should be 
considered.  
Arboviral and enteroviral encephalitis is treated with symptomatic and 
supportive care. Patients with headache should rest in quiet, dark environment and take 
analgesia. Narcotic therapy may be needed for pain relief. 
Treatment of post infectious encephalomyelitis is supportive. However, 
corticosteroid treatment may be effective (61). 
 
Complications: The Complications of severe encephalitis include; seizures, increased 
intracranial pressure and respiratory decompensation (61).       
Prognosis: Supportive care and rehabilitation are important after the patient recover. 
 XXXIII
The prognosis depends on the cause and severity of the illness and the 
patient’s age. If the clinical illness is severe and substantial parenchymal  involvement 
is evident, prognosis is poor (61). 
 
ACUTE TRANSVERSE MYELITIS (ATM): 
 
Transverse myelitis is a neurological disorder caused by inflammation across 
both sides at one level, or segment, of the spinal cord. The term myelitis referes to 
inflammation of the spinal cord, transverse simply describes the position of the 
inflammation, that is, across the width of the spinal cord. Attacks of inflammation can 
damage or destroy myelitis, the fatty insulating substance that covers nerve cell fibers. 
This damage cause nerves system scars that interrupt communication between the 
nerves in the spinal cord and the rest of the body (62). 
Symptoms of transverse myelitis include Loss of spinal cord function over 
several hours to several weeks. What usually besines as a sudden onset of lower back 
pain, muscle weakness, or abnormal sensation in the toes and feet can rapidly progress 
to more severe symptoms, including paralysis, urinary retention, and loss of bowel 
control. Although some patients recover from transverse myelitis with minor or no 
residual problems, others suffer permanent impairments that affect their ability to 
perform ordinary tasks of daily living. Most patients will have only one episode of 
transverse myelitis; a small percentage may have a recurrence (62).  
The segment of the spinal cord at which the damage occurs determines which 
parts of the body are affected. Damage at one segment will affect function at that 
segment and segments below it. 
Transverse myelitis occurs in adults and children, in both genders, and in all 
races. No familial predisposition is apparent. 
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A peak in incidence rates appears to occur between 10 and 19 years and 30 
and 39 years (63). 
The inflammation that causes such extensive damage to nerve fibers of the 
spinal cord may result from viral infection, abnormal immune reactions, or insufficient 
blood flow through the blood vessels located in the spinal cord. Transverse myelitis 
also may occur as a complication of syphilis, measles, lyme disease and some 
vaccinations, including those for chicken pox and rabies. Cases in which a cause can 
not be identified    are    called Idiopathic (63). 
In post - infections cases of transverse myelitis, immune system appears to 
play an important role in causing damage to spinal nerves (63). 
  
Normal MRI has previously been reported in 7-50% of cases (64).   
As with many disorders of the spinal cord, no effective cure currently exists 
for people with transverse myelitis. Treatment is designed to manage and alleviate 
symptoms. Therapy generally begins when the patient first experiences symptoms (65).    
                                     
MULTIPLE SCLEROSIS: 
 
Background: Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the 
central nervous system (C.N.S) (66). In fact, only 1 of every 4 MS attacks is associated 
with a viral infection (67). 
The disease can present in different forms, such as primary progressive, 
relapsing remitting, relapsing progressive, and secondary progressive phenotypes. 
Genetic susceptibility factors may play a role, as the disease is more common in 
Caucasian populations living in northern latitudes (68). 
Multiple sclerosis may present in an acute and clinically fulminate form 
(termed Marburg variant of MS) or may present with concomitant optic nerve 
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involvement and necrotizing myelopathy (i.e. neuromyelitis optica or Devic's  
syndrome, considered by some to be an MS variant) (69). 
MS may present in various forms. Some patients have a predominance of 
cognitive changes, while others present with prominent ataxia, hemiparesis or 
paraparesis, depression, or visual symptoms (69). 
Optic neuritis presents clinically as orbital pain, at rest or during eye 
movement, and loss of vision. Patients may complain of patchy loss of vision and upon 
examination, central scotoma and an afferent pupillary defect may be found. Patients 
may experience color desaturation even with normal visual acuity, usually manifested 
as the perception of red color as different shades of orange or gray (70). Patients with MS 
may present with facial palsies or trigeminal neuralgia. In fact, the presences of 
bilateral facial weakness or trigeminal neuralgia strongly suggest the diagnosis of MS. 
Facial myokymia also may be a presenting symptom. Nystagmus (direction–changing) 
and internuclear ophthalmoplegia are other manifestations (70). 
 
C.S.F: Oligoclonal bands are distinct electrophoretic patterns that reflect substantial 
elevation of IgG produced by a restricted set of plasma cells and are demonstrated in 
CSF samples of approximately 85% of patients with MS (71). 
 
MRI of head or spine, with and without gadolinium, should be performed 
according to clinical suspicion for lesion localization. 
Typical MS lesions appear as T2 hypeerdnsities in the ? periventricular 
region, they have an ovoid appearance, and they involve only the white matter (72). 
Evoked potential testing (visual, auditory, or somatosensory) is especially 
helpful in detecting clinically silent lesions and documenting an organic basis for range 
complaints. The most sensitive evoked potentials (50-80% sensitivity) followed by the 
somatosensory potentials (50-70% sensitivity). 
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Medical care: Thus, preventing disease progression by using available medications is 
imperative in MS treatment, especially for patient who have been diagnosed early and 
probably will respond to treatment. 
Prevent disease progression by using the “ABC” immunomodulatory drugs 
(i.e. interferon beta –1a [Aronex], interferon 1b [Betaseron]) (73). 
 
Acute exacerbations: Highly effective treatment is intravenous (IV) methyl 
prednisolone, Ig for 3-5days. This medication may help expedite the timing of recovery 
but will not affect the actual degree of recovery. High dose steroid may work more 
effectively than oral steroids for the acute attack, and home IV therapy is recommended 
if the patient does not require hospitalization. Alternatively, high dose oral methyl 
prednisolone should be used, when feasible (74). 
Azathioprine also may be used as immunosuppressive treatments for MS (75). 
 
HYPOKALEMIC PERIODIC PARALYSIS: 
     
Hypokalemic periodic paralysis causes episodic weakness which usually 
affect proximal limb muscles more then distal ones; rarely ocular, bulbar, or respiratory 
muscle are affected. Respiratory muscle weakness may prove fatal. Meals rich in 
carbohydrate or sodium can provoke attacks. (76). 
Hypokalemic periodic paralysis may complicate thyrotoxicosis in oriental 
races which corrected by reversal of the hyperthyroidism. (77). 
Reflexes become hypoactive and cardiac arrhythmias may occur during 
attacks owing to low serum potassium. Men are more often affected because of 
decreased penetrance in women (76). 
 XXXVII
Diagnosis is established by demonstrating a low serum potassium level during 
a paralytic attack and by excluding secondary causes of Hypokalemia (76). 
  
The acute paralysis improves following the administration of potassium salts. 
Oral potassium chloride (0.2-0.4 mmol/kg) should be given to patients with severe 
weakness and repeated at 15-30 minutes intervals depending on the response of the 
ECG, serum potassium and muscle strength  (76). 
  
MYASTHENIA GRAVIS (MG): 
 
Background: MG occurs at all ages. Sometimes in association with a thymic tumor or 
thyrotoxicosis.It is commonest in young women with HLA-DR3; if thymoma is 
associated, older men are more commonly affected. . (78). 
The incidence of   MG is approximately 1:20, 000, affect women more than 
men by a ratio 3:2. Women in the third decade and men in the fifth decade have the 
peak incidence. Five to seven percent of cases are familiar however; no Mendelian 
inheritance pattern is demonstrated. (79). 
Onset is usually insidious, but the disorder is sometimes unmasked by 
coincidental infection that leads to exacerbation of symptoms. Exacerbation may also 
occur before the menstrual period and during or shortly after pregnancy. (78). 
Symptoms are due to available degree of block of neuromuscular transmission 
caused by autoantibodies binding to acetylcholine receptors; these are found in most 
patients with the disease and have a primary role in reducing the number of functioning 
acetylcholine receptors. Additionally, cellular immune activity against the receptors is 
found (78). 
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 Symptoms &signs: Patients present with ptosis, diplopia, difficulty in chewing or 
swallowing, respiratory difficulties, limb weakness or some combination of these 
problems (78). 
Weakness may remain localized to a few muscle groups, especially the ocular 
muscles or may become generalized. Symptoms often fluctuate in intensity during the 
day and this diurnal variation is superimposed on a tendency to longer term 
spontaneous relapses and remissions that may last for weeks. 
Nevertheless, the disorder follows a slowly progressive course and may have 
fatal outcome owing to respiratory complications such as aspiration pneumonia (78). 
Clinical examination confirms the weakness and fatigability of affected 
muscles. In most cases, the extra ocular muscles are involved, and this leads to ocular 
palsies and ptosis, which are commonly a symptomatic. Papillary responses are normal. 
The bulbar and limb muscles are often weak, but the pattern of involvement is variable. 
Sustained activity of affected muscles increases the weakness which improves after a 
brief rest. Sensation is normal and usually there are no reflex changes. (78). 
The diagnosis can generally be confirmed by the response to a short-acting 
anticholinesterase. Edrophonium can be given intravenously in a dose of 10 mg (1ml), 
2 mg being given initially and the remaining 8 mg about 30 seconds later if the test 
dose is well tolerated; in myasthenic patients, there is an obvious improvement in 
strength of weak muscles lasting for about 5 minutes. Alternatively, 1.5 mg of 
neostigmine can be given intramuscularly and the response then lasts for about 2 hours: 
atropine sulfate (0.6 mg) should be available to reverse muscarinic side effects. (78). 
 
Imaging: Lateral and anteroposterior x- ray of the chest and CT scans to demonstrate a 
co-existing thymoma, but normal studies do not exclude this possibility (78). 
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Laboratory & other studies: Electrophysiological demonstration of a decrementing 
muscle response to repetitive 2 or 3 Hz stimulation of motor nerves indicates a 
disturbance of neuromuscular transmission. 
Assay of serum for elevated levels or circulating acetylcholine receptor 
antibodies is another approach and has a sensitivity of 80 -90 % (78). 
 
Treatment: Medication such as amino glycosides, that may exacerbate myasthenia 
gravis, should be avoided.  Anti cholinesterase drugs provide symptomatic benefit 
without influencing the course of the disease (78). 
Neostigmine, pyridostigmine, or both can be used, the dose being determined 
on an individual basis. The usual dose of neostigmine is 7.5-30 mg (average, 15mg) 
taken four times daily. Overmedication may temporarily increase weakness, which is 
then unaffected or enhanced by intravenous edrophonium. 
Thymectomy usually leads to symptomatic benefit or remission and should be 
considered in patients younger than age of 60 years, unless weakness is restricted to the 
extra ocular muscles. If the disease is of recent onset and only slowly progressive; 
operation is sometimes delayed for a year or so, in the hope that spontaneous remission 
will occur. 
Treatment with corticosteroid is indicated for patients who have responded 
poorly to anticholinesterase drugs and have already under gone thymectomy. It is 
introduced with the patient in the hospital, since weakness may initially be aggravated, 
once weakness stabilized after 2-3 weeks or any improvement is sustained, further 
management can be on an out patient basis (78). 
Alternate-day treatment is usually well tolerated, but if weakness is enhanced 
on the non-treatment day it may be necessary for medication to be taken daily. The 
dose of corticosteroid is determined on an individual basis, but an initial high daily dose 
(e.g. prednisolone 60-100mg) can be gradually tapered to a relatively low maintenance 
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level as improvement occur; Treatment with azathioprine may also be effective. The 
usual dose is 2-3mg/kg orally daily after a lower initial dose. 
In patients with major disability in whom conventional treatment is either 
unhelpful or contra-indicated, plasmapheresis or intravenous immunoglobulin therapy 
may be beneficial. It may also be useful for stabilizing patients before thymectomy and 
for managing acute crises (78). 
 
 
FRIEDREICH’S ATAXIA: 
 
This autosomal recessive disorder, is relatively common with a prevalence of 
about 1 in 100,000 (80). 
This is the most common from of internal ataxia, comprising one – half of all 
hereditary ataxia (81). 
It can occur in a classic form or in association with a genetically determined 
vitamin E deficiency syndrome (81). 
Symptoms and signs: Friedreich's ataxia presents before 25 years of age with 
progressive staggering gait, frequent falling and titubation. The lower extremities are 
more severly involved than the upper ones. Dysarthria occasionally is the presenting 
symptoms, and rarely progressive scoliosis, foot deformity, nystagmus, or 
cardiomyopathies are initial signs (81). 
The neurological examination reveals nystagmus, loss of fast saccadic eye 
movements, truncal titubation, dysarthria, dysmetria, and ataxia of extremity and 
truncal movements. Extensor planter responses (with normal tone in trunk and 
extremities), absent deep tendon reflexes and weakness (greater distally than 
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proximally) are usually found. Loss of vibration and proprioceptive sensation occurs. 
The median age of death is 35 years (81). 
Cardiac involvement occurs in 9 percent of patient with Friedreich’s ataxia 
(81).  
The primary site of pathology is the spinal cord and the peripheral nerves, 
slight atrophy of the cerebellum and cerebral gyri may occur (81).  
Sclerosis and degeneration are seen predominantly in the spinocerebellar 
tracts, lateral corticospinal tract, and posterior columns. Degeneration of the 
glossopharyngeal, vagus, hypoglossal, and deep cerebellar nuclei is described. The 
cerebral cortex is histologically normal except for loss of Betz cells in the precentral 
gyri (81). 
Treatment: There is no effective treatment. Symptomatic treatment of scoliosis by 
orthopaedic intervention and cardiac abnormalities by appropriate medication may 
prolong survival (80).    
 
HUNTINGTON DISEASE: 
 
It is genetic, autosomal dominant, degenerative brain disorders. Frequency 
10/100,000. The two clinical hallmarks of the disease are chorea and behavioral 
disturbance (82).   
The average age at onset is 35 to 45 years. Personality changes, memory loss, 
and attention deficits are common signs. Depression is also prominent in many patients. 
The autosomal dominant inheritance is fully penetrante and confers a 50% risk of 
passage to off spring of affected individuals (83). 
Neuropathologically, the disease predominantly strikes the striatum. Atrophy 
of caudate nuclei can be visualized in the middle and late stages of the disease (82). 
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There is gliosis and neural loss, especially of medium sized neurons in the 
caudate and putamen (82). Also there is neural loss in the fourth and fifth layer of the 
cerebral cortex of the frontal lobe (84). 
Diagnosis of Huntington’s disease has been simplified since a direct genetic 
test became commercially available. a (CAG) repeat number higher than 39 in the 
Huntington’s disease gene is diagnostic (85). 
CT-scan usually demonstrates cerebral atrophy of the caudate nucleus in 
established cases (86). 
If the patient presents solely with progressive intellectual failure, it may not 
be possible to distinguish Huntington’s disease from other causes of dementia unless 
there is a characteristic family history or adyskinesia develop (86). 
At present, there is no treatment to prevent the progression of Huntington’s 
disease. Patients are given symptomatic treatment for the chorea as clorazepam (85). 
 
CHARCOT-MARIE-TOOTH (CMT) DISEASE: 
 
Several distinct varieties of CMT disease can be recognized. There is usually 
an autosomal dominant mode of inheritance, but occasional cases occur on sporadic, 
recessive or X-linked basis (87). 
The responsible gene is commonly located on the short arm of chromosome 
17 and less often showed linkage to chromosome 11 or X-chromosome (87). 
  
Hereditary motor and sensory neuropathy (HMSN) type1 and type II, usually 
present during childhood or adolescence with difficulty in walking or because of foot 
deformity. The deformity is most commonly pes cavus associated with clawing of the 
toes and sometimes with equinovarus position of the foot. Muscle weakness tends to 
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affect the lower leg muscles and may give rise to a bilateral foot drop with a steppage 
gait. The muscle wasting is often restricted to below the knee producing stork leg 
appearance (87). 
Weakness and wasting of the small hand muscles appear later. The tendon 
reflexes become depressed or lost and there is a variable degree of distal sensory loss.      
Sensory loss and ataxia tend to be greater and generalized tendon areflexia is 
usual. Weakness in the hands appears earlier. The peripheral nerves may be thickened. 
Cases with ataxia are sometimes referred to as the Roussy-Levy syndrome. They are 
not genetically distinct. The onset in type II form is most often in the second decade but 
it may be delayed until middle or even late adult life. Some families with type II show 
genetic linkage with the Duffy blood group (87). 
 
SYRINGOMYELIA:- 
 
Syringomyelia is the development of a fluid filled cavity or syrinx within the 
spinal cord. Hydromyelia is a dilatation of the central canal by CSF and may be 
included within the definition of Syringomyelia (88). 
 
Types of Syringomyelia include the following:- 
Syringomyelia with fourth ventricle communication is representing about 
10% of cases.  
Syringomyelia due to spinal cord injury: fewer than 10% of syringomyelia 
cases are of this type (88).  
 
History: Syringomyelia usually progress slowly, the course may extend over many 
years (89).  
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Sensory, syrinx interrupts the decussating spinothalamic fibers that mediate 
pain and temperature sensibility, resulting in loss of these sensations, while light touch, 
vibration, and position senses are preserved. When the cavity enlarges to involve the 
posterior columns, position and vibration senses in the feet are lost; astereognosis may 
be noted in the hands. Pain and temperature sensation may be impaired in either or both 
arms or in a shawl like distribution across the shoulders and upper torso anteriorly and 
posteriorly. Motor syrinx extension into the anterior horns of the spinal cord damages 
motor neurons and causes diffuse muscle atrophy that begins in the hands and 
progresses proximally to include the forearms and shoulder girdles. Claw hand may 
develop (89). 
An anatomic, impaired bowel and bladder function usually occurs as a late 
manifestation. Sexual dysfunction may develop. Horner syndrome may appear, 
reflecting damage to the sympathetic neurons in the intermediolateral cell column (80). 
Asyrinx may extend into the medulla, producing asyringobulbia. This 
syndrome is characterized by dysphagia, nystaymns, pharyngeal and palatal weakness, 
asymmetric weakness and atrophy of the tongue, and sensory loss involving primarily 
pain and temperature sense in the distribution of the trigeminal nerve (89). 
Physical: Arm reflexes are diminished early in the clinical course. Lower limb 
spasticity, which may be asymmetrical, appears with other long – tract sign such as 
paraparesis, hyper reflexia, and extensor planter responses. Dissociated sensory 
impairment may be noted. The syrinx may extend into the brainstem, affecting cranial 
nerves or cerebellar function. Brainstem signs are common in syringomyelia associated 
with Chiari malformations (88).  
MRI examination should include sagittal and transverse views in T1 and T2 
images proton density sans also can be helpful (90).  
MRA: can be especially helpful in cases of syringomyelia associated with 
vascular lesions (90).  
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Surgical care: Sub-occipital and cervical decompression, laminectomy, syringoitomy, 
Ventriculoperitoneal shunt, lumboperitoneal shunt and syringoperitoneal shunt (91).  
 
ARNOLD-CHIARI MALFORMATION: 
 
More than half of all cases of syringomyelia are associated with Chiari 
malformation (92).      
 
 
Classification: 
Type-I: It is characterized by downward displacement of the cerebellum with 
elongation of the medulla such that the cerebellar tonsils egress through the foramen 
magnum into the cervical spinal canal. It is not associated with other nervous system 
malformation (93).      
  
Type-II: By definition; this type is associated with a lumbosacral myelomeningocele 
and with numerous other nervous system malformations (93).      
 
Type-III: An occipital encephalocele with protrusion of cerebellar remnants into the 
overlying sac (93).      
 
Type-IV: Isolated hypoplasia of the cerebellum not associated with other nervous 
system malformations (93).      
In patient with Arnold-Chiari malformation, there are commonly skeletal 
abnormalities on plain x-rays of the skull and cervical spine. CT scans show caudal 
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displacement of the fourth ventricle. MRI or positive myelography may demonstrate 
the malformation itself. Focal cord enlargement is found at myelography or by MRI in 
patients with cavitations related to past injury or intramedullary neoplasm (93).      
. MRI scan accurately identify syrinx cavities and associated spinal cord 
enlargement (92).       
Treatment of Arnold-Chiari malformation with associated syringomyelia is by 
suboccipital craniotomy and upper cervical laminectomy, with the aim of 
decompressing the malformation at the foramen magnum (93).       
   
 
 
 
 
 
 
Objectives:  
 
To study the clinical pattern and the aetiology of non traumatic quadriparesis 
in Sudanese patients. 
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PATIENTS & METHODS 
METHODOLOGY: 
? Study design :       Descriptive cross sectional. 
? Study field    :         Alshaab Teaching Hospital. 
                                         Department of neurology                                    
? Study population:  patients with all four limbs weakness. Admitted to 
the hospital from Jan 2002 - Oct 2003.        
? Inclusion criteria: 
           1- Adult Sudanese patients with four limbs weakness. 
? Exclusion criteria: 
        1- Patient below 18 years of age. 
        2- Patient with traumatic quadriparesis. 
         3- Psychogenic quadriparesis  
? Sampling: 
• Sample size:           100 patients. 
• Sample design:       Systematic random sample. 
•  Sample frame:         List by registration number. 
? Tools of data collection:  
           Data were collected by: 
           1- Pre-design questionnaire. 
           2- Clinical examination. 
           3- Investigations. 
? Data entry &analysis: 
           Data was introduced into the computer from a master sheet recording. 
Using S.P.S.S. software program, data were entered and analyzed using the 
student t-test.  
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• Age was grouped into: 
         18-24, 25-34, 35-44, 45- 54, 55-64, 65-74, >75. 
• Residence was classified as: 
         Khartoum state, central, west, east, north and south. 
• Symptoms considered as: 
         1-Antecedent event in form of: 
            Fever, headache, neck pain and backache.         
         2-Presenting complains: 
            Weakness, sensory complaint, sphincteric dysfunction,  
            cranial nerves and cortical symptoms. 
         3-Physical signs were grouped into; 
            General examinations, systemic and neurological. 
         4-Neurological examinations were further arranged into: 
            Higher mental function, cranial nerves, upper limbs, trunk and  
            lower limbs. 
         5-Work up as: 
            General and specific investigations.  
         6-The specific investigations: 
            Imaging, CSF, NCS, EMG and CPK level. 
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RESULTS 
 
• Table 1 showed that patients of age group distribution 18-24 to be (21%). 25-34, 
13%. 35-44, 21%. 45-54, 13%. 55-64, 16%. 65-74, 13% and > 75, 3%. 
• Table 2 showed the antecedent events, fever was reported in 25%, headache in 14%, 
neck pain in 16% and backache in 25%. 
•  Table 3 showed weakness was reported in all (100%) patients, sensory symptoms 
were reported by 30% and cranial nerves symptoms were reported by 21%. 
• Table 4 showed that 4% of patients had cortical symptoms, 14% had urinary 
sphincteric dysfunction and 2% had bowel sphincteric dysfunction. 
• Table 5 showed that cervical cord compression was the final diagnosis in 26% 
followed by A.I.D.P. 16%, C.I.D.P. 15%, muscular dystrophy 10%, M.N.D. 10%, 
S.O.L. 4%, dermatomyositis 3%, 2% for each of neurobrucellosis, bilateral infarct, 
encephalitis and A.T.M. 1% for each of M.S, C.M.T, MG, hypokalaemic periodic 
paralysis, friedrich's ataxia, Huntington disease, Arnold chiari malformation and 
syringomyelia. 
• Table 6 showed that 56% of patients had abnormal MRI while 13% had normal MRI. 
• Table 7 showed that the levels of the lesion to be UMNL in 37% of patients diffuse 
LMNL in 47% and myopathy in 16% of patients. 
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• Figure 1showed that 55% of patients are male and 45% are female. 
• Figure 2 showed that 38% of the patients are resident in Khartoum, 28% in central, 
19% in the north, 8% in the west, 6% in the east and only 1% in the south. 
• Figure 3 showed that the onset was gradual in 75% of the patients, rapid in 20% and 
sudden in just 5%. 
• Figure 4 showed that urinary sphincter disturbance occurred in 14% of patients while 
the remainder had no sphincteric disturbance. 
• Figure 5 showed that the bowel sphincter disturbance occurred in only 2% of the 
patients while the remainder had no disturbance. 
• Figure 6 showed that 38% of the patients had upper limbs muscles wasting while no 
wasting was seen in 62% of the patients. 
• Figure 7 showed that 32% of the patients had lower limb muscle wasting, while no 
wasting was seen in 68% of the patients. 
• Figure 8 showed the state of tone in the upper limb; 47% had hypotonia, 31% had 
normal tone and 22% had hypertonia. 
• Figure 9 showed the state of tone in the lower limbs; 51% had hypotonia, 30% had 
hypertonia and 19% had normal tone. 
• Figure 10 showed the state of the reflexes in the upper limbs; 50% of the patients had 
absent reflexes, 29% had brisk reflexes and 21% had normal reflexes. 
• Figure 11 showed the state of reflexes in the lower limbs; 51% had absent reflexes, 
42% of the patients had brisk reflexes and 7% had normal reflexes. 
• Figure  12 showed that the power in the upper limbs was grade 0 in 3% of the 
patients ,grade I  in 6% ,grade II in 20% ,grade III in 46% ,grade IV in 19% ,while the 
power in the lower limbs was grade 0 in 9% of the patient, grade I in 6%, grade II in 
33%, grade III in 34% and grade IV in 15%. 
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• Figure 13 showed that 40%of the patients had equivocal planter response, 33% had 
extensor planter response and 27% had flexor planter response. 
• Figure 14, showed that the sensation of the upper limbs was normal in 79% of the 
patients, decrease in 20% and absent in 1%, while the sensation in the lower limbs was 
normal in 76% of the patients, decrease in 20% and absent in 4%. 
• Figure 15, showed the abdominal reflexes were absent in 59% of the patients and 
were present in 41%. 
• Figure 16, showed that 97% of the patients could walk with support and 14% could 
walk independently and 39% were wheel-chair dependent. 
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TABLE NO-1:- 
? Age distribution of patients: 
 
            Age group   Number of patients 
18-24 21 
25-34 13 
35-44 21 
45-54 13 
55-64 16 
65-74 13 
>75 3 
Total 100 
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TABLE NO-2:- 
 
? Antecedent events: 
 
 
 Symptoms    Fever  Headache  Neck pain  Backache 
    Percent      25%      14% 1        16%       25% 
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TABLE-NO-3:- 
 
? The presenting symptoms 
 
 
  Symptom    Weakness    Sensory   Cranial nerves 
     Percent        100%        30%            21% 
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TABLE-NO-4 
 
? Concomitant cortical & sphincteric dysfunction 
 
 Symptom   Cortical   Urinary   Bowel 
   Percent       4% 1      14%     2% 
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TABLE-NO-5 
? The different diagnoses: 
Diagnosis Percent 
Cervical cord compression 26 
A.I.D.P 16 
C.I.D.P 15 
Muscular dystrophy 10 
M.N.D 10 
S.O.L 4 
Dermatomyositis 3 
Neurobrucellosis 2 
Bilateral infarct 2 
Encephalitis 2 
A.T.M. 2 
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M.S 1 
Hypokalaemic periodic paralysis 1 
Myasthenia gravis (MG) 1 
Friedrich's ataxia 1 
Huntington disease 1 
Charcot  Marie Tooth 1 
Syringomyelia 1 
Arnold chiari malformation 1 
Total 100 
                                                  
 
 
 
 
 
TABLE- NO-6 
 
? The MRI 
 
The result Normal Abnormal 
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Percent 13% 56% 
                                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE-NO-7 
 
? The level of the lesion 
 LX
 
   The level UMNL    Diffuse LMNL  Myopathy 
    Percent 37% 47% 16% 
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DISCUSSION 
 
This is the first study carried out in respect to individual etiologies and 
clinical presentation of quadriparesis in Sudan. 
 
21% of cases in the study lie in the age group of 18 -24, 13% in the age 
group of 26-34, 21% in the age group of 35-44, 13% in the age group 65-74 and 
only3% their age more than 75 years. In conclusion, more than half of the patients 
(55%) lie in the age group of 18-44, who are the most active sector of the community. 
(Table1).    
Males (55%) were more affected than females (45%). (Figure1). 
The majority of patients from Khartoum state and the surroundings (38%), 
followed by the central states (28%), the north states (19%), the west states (8%), the 
east states (6%) and only1% for the southern states. This can be explained by the 
migration toward Khartoum and the war in the south, but no significant geographical 
etiological factor is suspected .(Figure2). 
Family history of neurological disease was reported in 1% of the patients, 
had Huntington disease. 
       Weakness was the presenting complaint in all (100%) patients, followed by 
sensory symptoms in form of tingling or numbness in 30%, but examination of the 
upper limbs sensation showed decrease in 20% and absent sensation in 1%, while the 
sensation in the lower limbs was decreased in 20% and absent in 4%. (Table 3 ) and ( 
figure14) . 
Urinary sphincteric dysfunction was reported in 14%, while bowel 
sphincteric dysfunction was reported in 2%.( Table 4 ) . 
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Backache was reported in 25% and neck pain in 16%.( Table 2 ). 
 
Only 4% of the patients had cerebral symptoms (convulsion and confusion). 
(Table4).  
21% of patients had cranial nerve symptoms with same percentage had 
positive sign on examination. The facial nerve is commonly affected in (11%); 8% 
bilaterally and 3% unilaterally, followed by the optic nerve 4%, the bulbar cranial 
nerves (9th,10 th,11 th,12 th) 3%, and 1% for the oculomotor cranial nerve .(Table 3). 
The power in the lower limbs was grade 0 in 9%, grade I in 6%, grade II in 
33%, grade III in 34% and grade IV in 15%. This is compatible with the degree of 
disability, which was 14% in patients who experienced no disability, 47% in patients 
who are able to walk with support, and 39% of patients who are wheel chair bound. 
(Figure12 &16). 
The state of tone in the upper limbs was flaccid in 47%, normal in 31% and 
spastic in 22%.While the percentage of brisk reflexes were higher in absent in 50%, 
and normal in21%. This is because some patients still had brisk reflexes despite 
hypotonia or normal tone. Figure 8 &10. 
Similarly, the state of tone in the lower limbs was flaccid in 51%, normal in 
19% and spastic in 30%.While the percentage of brisk reflexes were higher (42%), 
absent in 51%, and normal in7 %. Also, this is because some patients still had brisk 
reflexes despite hypotonia or normal tone. (Figure 9 &11). 
Cerebellar ataxia was present in 2% of patients diagnosed as MS and 
Friedriech’s ataxia. 
The planter response was extensor in 33% of patients; most of them had 
cervical cord compression (26%). (Figure13).  
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In this study cervical cord compression constitutes the first major cause of 
quadriparesis (26%).The age distribution of the patients, 43% more than 60 years, 
27% between 45-60 years and 30% between 18-44 years. The gender of the patients is 
approximately equal.  The onset of symptoms found to be gradual in 84% of patients. 
This reflect that the common cause of cervical cord compression is the cervical 
spondylosis which is insidious in onset. Neck pain was reported in 53%, while 
backache in 38% and headache in 8%. This reflects that the majority of patients 
presented with neck pain and limitation of neck mobility. Associated headache 
occurred in the posterior region which involve upper cervical spine (C2-C4). Sensory 
symptoms were reported in 30%, urinary sphincteric disturbance was reported in 20%, 
while bowel sphincteric disturbance was reported in 8%.  Examination of the upper 
limbs showed wasting in 42%, hypertonia in 42%, brisk reflexes in 50% and decrease 
sensation in 23% of cases. Abdominal reflexes were absent in 85% of patients. 
Examination of the lower limbs showed wasting in 34%, hypertonia in 69%, brisk 
reflexes in 77% and decreased sensation in 19% of cases.  Planter response was up 
going in 69% of patients and equivocal in the reminder 31%. This reflects spasticity 
with exaggerated reflexes and extensor planter responses is the feature of cervical 
spondylosis as UMNL. The degree of disability of gait showed; the patients walk with 
support were about 72% and those who need wheel chair were 24%. MRI detects the 
diagnosis at all patients (100%). 
The most common cause of cervical cord compression in this study is 
cervical spondylosis which was reported in 21 patients followed by Pott’s disease in 2 
patients and one patient with spontaneous extradural haematoma, cervical cord tumor 
and rheumatoid arthritis complicated atlantoaxial dislocation. 
 
In this study AIDP constitute the second cause of quadriparesis (16%). As in 
many other studies no age group is exempted (94).. Male to female ratio is 2.2:1. Fever 
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was reported by 44% of patients, this reflect the role of infections as antecedent 
causative factor.13% of the patients need ICU admission and ventilatory support. This 
is compatible with asimilar study done at India (95). Urinary sphincteric disturbance 
reported in 6% (1/16).this reflect no variation from literature reports and this occur 
lately in the course of AIDP (18). Facial weakness had occurred in 56%, (19% 
unilaterally and 37% bilaterally), while (9th, 10th, 11th) in 6%. This was compatible 
with literature reports (12). Reflexes of the upper limbs were absent in 94%. While all 
(100%) patients had absent lower limbs reflexes (12, 16). CSF protein was raised in 75% 
of patients which is compatible with other studies that showed 65-85% increase in 
CSF protein (14). 
 
CIDP constitutes the third cause of quadriparesis (15%). The study showed 
that male to female ratio is 3:2. No age group is exempted. Upper limb reflexes were 
absent in 80% of patients, while lower limbs reflexes were absent in 93% of patients. 
Only one patient showed cranial nerve abnormality in the form of bilateral facial 
nerve palsy. 94% of the patients had significant high CSF protein (14).  67% of the 
patients had done NCS, which confirm the diagnosis in all of them. 
 
10% of the patients in this study were diagnosed as Muscular Dystrophy. 
90% of the patients ages less than 35 years. Which reflect the early onset of the 
disease (27). Male to female ratio is 4:1. Examination of the upper limbs showed 
wasting in 40% of the patients, 60% absent reflexes and all patients had normal 
sensation. While examination of the lower limbs showed 60% of the patients had 
absent reflexes and 40% had hypertrophy pseudohypertrophy of the calf muscles. All 
patients showed marked increase in the level of CPK (27). 90% diagnosed as Limb 
Girdle Muscular Dystrophy, while 10% diagnosed as Becker Muscular Dystrophy. 
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10% of the patients in this study diagnosed as MND. Male to female ratio is 
1:1. All patients had no history of fever, neck pain cortical symptoms, and bowel and 
sphincteric disturbances. 20% of the patients had symptoms due to the cranial nerve 
involvement. The abnormal cranial nerves include (5th, 7th , 9th , 10th , 11th , 12th) ),this 
reflects the affection of MND to the motor nuclei of these cranial nerves.  Lower 
limbs examination showed wasting in 90% of the patients, spastic tone in 30%, brisk 
reflexes in 40% and normal sensation in all patients (100%). Upper limbs examination 
showed wasting in 80% of the patients, spastic tone in 30%, brisk reflexes in 80%, up 
going planter in 50% and normal sensation in all patients (100%).This reflect the 
involvement of both UMNL and LMNL in MND leading to weakness and wasting of 
muscles without accompanying sensory changes.  50% of the patients did MRI, all of 
them were found to be normal. 30% of the patients did EMG and the diagnosis of 
MND was confirmed in all of them. 
4% of the patients had SOL, 25% of them had cortical symptoms. MRI 
elicits the diagnosis in all patients. 
             3% of the patients had dermatomyositis. All of them were females, two of 
them had positive rheumatoid factor (RF) and the other one had positive antinuclear 
factor (ANA).Muscle biopsy confirm the diagnosis in all three patients. 
2% of the patients were diagnosed as neurobrucellosis. The two patients are 
male and had strong history of contact to animals. The spastic tone, brisk reflexes and 
up going planter reflexes were noticed in the two patients. The diagnosis was highly 
suggested by high significant titer. 
     2% of the patients were diagnosed as bilateral cerebral infarction. The two 
patients were female of middle age and have spastic tone, brisk reflexes and up going 
planter reflexes. The risk factor in one patient was hypertension for more than 20 
years, while the other one was found to have antiphospholipid syndrome. 
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     2% of the patients had viral encephalitis, in which the diagnosis was 
suggested by EEG. 
     2% of the patients had acute transverse myelitis (ATM), one patient had 
given anti-rabies vaccine two weeks previous to the weakness (63). The onset of the 
disease was rapid. 
1% of the patients had hypokalemic periodic paralysis. The patient was a 
young male; develop sudden quadriparesis without any preceding symptoms. He 
found to be hypotonic; power of grade 0, normal sensation and absent reflexes. The 
mental function and cranial nerves were normal. Serum potassium was found to be 1.9 
mmol/l. The patient recovered after administration of potassium chloride 
intravenously. 
      1% of the patients had MG. the patient was a male, middle age, developed 
rapid course of weakness with bilateral ptosis, with flaccid tone, absent reflexes and 
normal sensation. The diagnosis was confirmed by neostigmine test. 
              1% of the patients had Friedrich’s ataxia. The patient was young male, 
gradual onset weakness .No family history of similar condition or neurological 
disease. The patient had marked wasting of all muscle groups of his upper and lower 
limbs, pes cavus, bilateral foot drop and ataxia. 
  1% of the patients had MS. the patient was a female, middle age, develop 
headache, unsteady gait and loss of vision of her right eye. Examination showed; 
secondary optic atrophy, absent abdominal reflexes and bilateral extensor planter 
response. MRI suggests the diagnosis. 
         1% of the patients had Huntington disease. The patient was a female, 
middle age, developed involuntary abnormal movement in both upper and lower limbs 
and dementia. The patient had strong family history of similar condition (two brothers 
and one sister). MRI showed brain atrophy. 
     
 LXVII
1% of the patients had CMT. The patient was young male, had marked 
wasting, claw hand and bilateral pes cavus. 
           1% of the patients had syringomyelia. The patient was young female, presented 
with weakness, paraesthesia. She had dissociated sensory loss. The diagnosis was 
confirmed by MRI.  
1% of the patients had Arnold Chiari malformation. The patient was middle 
age female, presented with difficulty in speech with nasal tone. She had impaired gag 
reflex. MRI confirms the diagnosis.  
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CONCLUSION 
 
• Male to female ratio was 1.22:1, most of the patients were from Khartoum state 
and central states. 
• Most of the patients present with gradual onset  
• Weakness was the presenting complaint in all patients 
• Fever and backache were the presenting complaint in 25% of the patients. 
• Wasting of the upper limbs was seen in more than one-third of the patients, while it 
was less than one- third in the lower limbs. 
• The tone was flaccid in approximately half of the patients. 
• The sensation was normal in more than two third of the patients. 
• The planter was extensor in one-third of the patients. 
• Weakness due to UMNL was reported in more than one-third of the patients. 
• More than one-third of the patients were wheel chair bound. 
• MRI was of great help in picking up brain and cord pathology. 
• NCS and EMG were of great help to pick up the diagnosis of diffuse LMNL and 
myopathy. 
• Cervical cord compression, AIDP, CIDP, MND and Muscular Dystrophy are the 
major etiologies of quadriparesis in Sudan. 
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RECOMMENDATIONS 
 
 
• Al Shaab Teaching Hospital is the tertiary specialized hospital in the country 
concerned with the diagnosis and management of patients with neurological diseases.  
• It received the load of patients from all the states of Sudan . Inspite of this it so 
deficient in equipments and diagnostic tools .  
• Establish many neurological centers throughout the country, connecting to the 
international center of neurology at Al Shaab Teaching Hospital, inform of training, 
workshops, research studies and conferences. 
• Patients with neurological diseases need special wards, diagnostic material, 
rehabilitation centers, psychotherapy and medications. 
• Establish societies to help these patients with aiding tools and for psychological 
support. 
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 LXXVII
PATTERNS OF CLINICAL PRESENTATION OF 
NON TRAUMATIC QUADRIPARESIS IN 
SUDANESE PATIENTS 
 
Protocol: 
Name: --------------------------------------------------- Age: ------------- Sex: -------
Residence :( Previous – Current) -------------------------------------------------- 
Tribe: -------- Job: -----------    Marital Status: ------ Special Habit ------------- 
 
Symptoms preceding onset: 
                                                             Yes                  No             Date 
- Fever                                               -------                -------          ------- 
- Headache                                       -------                -------          ------- 
- Vomiting                                        -------                -------          ------- 
- Blurring of vision                         -------                 -------          -------                                           
- Cough                                            -------                 -------          ------- 
- Diarrhoea                                      -------                 -------          ------- 
- Neck pain                                      -------                 -------          ------- 
-Upper limb weakness                   -------                 -------          ------- 
- Backache                                        -------                 -------          -------     
-Paraesthesia  or Numbness         -------                 -------          -------                                 
-Unsteadiness                                 -------                 -------          ------- 
-Trauma                                           -------                 -------          -------  
 
Symptoms at onset: 
 
Gradual ---------------- Rapid ----------------- Sudden ---------------  
 
Symptoms of cranial nerve affection: 
 
---------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------  
1-Sensory:                                          Yes                        No  
Loss                                         -------                    -------           
Paraesthesia                           -------                    -------           
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2-Motor: 
Weakness                               -------                     -------           
Unsteadiness                          -------                    -------           
Stiffness                                  -------                    -------   
3-Sphincter disturbance                 Yes                        No 
Urinary                                   -------                    -------           
Faecal                                      -------                    -------           
Impotance                              -------                    -------           
Cortical:                                            Yes                        No 
 
         1- Attend consciousness       -------                    -------- 
         2- Seizures                                -------                    -------- 
         3- Others –specify                    -------                   -------- 
 
Other Systems:- 
---------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------- 
Co-morbidity: 
                                                 Yes               No              Date  
    S/C                                     -------            -------          ------- 
    Trauma                              -------            -------          --------   
    Fever                                  -------            -------          -------- 
    D.M                                    -------            -------          -------- 
    Hypertension                   -------            -------          -------- 
    T.B                                      -------            -------          -------- 
    Syphilis                              -------            -------          ------- 
    Neurological disease       -------            -------          -------- 
    Drugs                                 -------            -------          -------- 
 
 F.H: Consanguinity -------------------------- 
   S/C                                      -------            -------          ------- 
  Neurological disease         -------            -------          ------- 
  Chronic disease                  -------            -------          ------- 
 
Physical examination: 
 
General                    1- Fever --------------      2- Anemia ------------ 
                                   3-Dehydration -------- 4-Tachypnoea --------  
                                   5- BP ------------------     6- Pulse ----------------- 
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         Neck: -------------------------------------------------------------------------------- 
 
         C.V.S: ------------------------------------------------------------------------------- 
 
         Chest: ------------------------------------------------------------------------------- 
 
         Abdomen: ------------------------------------------------------------------------- 
 
         Back & spine: --------------------------------------------------------------------- 
 
Nervous system:  
 
1- Mental function test : Glasgow coma scale (    )   
Orientation in time, place& person (   ). Concentration (   ). Memory (   ). 
Mood (   ). Intelligence (   ). Speech (   ). 
Comment: -------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------ 
 
2-Cranial nerves  
I(   ), II(   ), III(   ), IV(   ),V(   ), VI(   ), VII(   ), VIII(   ), IX(   ), X(   ), XI(   ), XII(   
). 
Comment: -------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------- 
 
3-Upper limbs 
Inspection (Bulk, atrophy, posture, abnormal movements) --------- 
Tone ---------------------------------------  
Power (Grade) -------------------------- 
Reflexes:    2-increased, 1-normal,  0-absent 
                     Supinator ---------------- Biceps -------------Triceps -------- 
Sensation: 2-normal, 1-decreased, 0-absent  
Light touch ------------Pin brick ------------------  
Joint position ------------------------- Vibration -------------  
Co-ordination ---------------------------------------------------------- 
    
4-Trunk --------------------------------------------------------------------------------- 
  Abdominal reflexes               Present           Absent 
  Upper quadrant                       -------            -------           
  Lower quadrant                       -------            ------- 
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5- Lower limbs 
Inspection (Bulk, atrophy, posture, abnormal movements) ---------- 
Tone ----------------------------------------  
Power (Grade) ---------------------------- 
Reflexes:    2-increased, 1-normal, 0-absent 
       Ankle ---------------------- Knee ------------------------- 
               Planter response ------------------ Clonus ---------------- 
         Sensation   2-Normal, 1-Decreased, 0-Absent 
       Light touch ------------Pin brick ------------------  
       Joint position ------------------------- Vibration ---------------  
Co-ordination ---------------------------------------------------------- 
 
6- Others: 
Skull --------------------------------------------------------   Gait ----------------  
Type (Walk independent, with help, cannot walk) ---------------------- 
7- Investigations: 
 
• CBC. 
• ESR. 
• RBS. 
• B. urea & electrolyte. 
• VDRL. 
• Urine general. 
• Stool general. 
• Mantaux test. 
• CXR. 
• CSF. 
• Cervical X-ray. 
• CT-Scan. 
• MRI. 
• NCS. 
• EMG. 
 
 
